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Purpose: To evaluate the in vitro formation of 3D tissue engineered constructs (TECs) 
using rabbits’ annulus fibrosus (AF) cells seeded on poly(lactic-co-glycolic acid) (PLGA) 
based scaffolds. 
 
Methods: Porous disc-shaped PLGA was fabricated using solvent casting and salt leaching 
technique. It was crosslinked with atelocollagen to form “PA”scaffold group. Fibrin was 
added to PLGA and PLGA-atelocollagen composite to form “PF” and “PAF” scaffolds, 
respectively. The AF cells were seeded into the prefabricated scaffolds (1.0x105 cells per 
scaffold) to form the following TECs groups: AF+PLGA (AFP; control), 
AF+PLGA+atelocollagen (AFPA), AF+PLGA+fibrin (AFPF) and AF+PLGA+atelocollagen+fibrin 
(AFPAF). The resulting TECs were cultured for three-week and evaluated for cells viability 
using MTT assay, cellular morphology and attachment using SEM, cartilaginous matrix 
production using sGAG assay and DNA content using PicoGreen® assay. 
 
Results: Significant number of viable cells was observed in the AFPAF group 
(987,985.7±286,858.9 cells)when compared to other TECs(AFP: 373,319.0±5,456.9; AFPA: 
547,763.4±66,038.2; AFPF: 463,763.4±46,160.8 cells). Cellular morphology and attachment 
were comparable in all TECs. The AFPA has the highest sGAG accumulation (0.279±0.117 
mg/ml) but shows no statistical difference when compared to the other TECs (AFP: 
0.083±0.038; AFPF: 0.237±0.131; AFPAF: 0.181±0.024 mg/ml).The AFPF has the highest 
DNA content (1,919.338±89.050 ng/ml) but shows no statistical difference when compared 
to the other TECs (AFP: 485.659±27.468; AFPA: 845.987±82.134; AFPAF: 
1,575.007±307.174 ng/ml). Hence, atelocollagen seemed to provide better environment for 
cellular attachment and proliferation. This unique collagenous material also promotes sGAG 
production and DNA content in TECs. 
 
Conclusion: The incorporation of atelocollagen into PLGA scaffold enhances the formation 
of TECs in vitro. 
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